about
Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)Applications of chemogenomic library screening in drug discoveryInduction of Macrophage Function in Human THP-1 Cells Is Associated with Rewiring of MAPK Signaling and Activation of MAP3K7 (TAK1) Protein KinaseIsolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analoguesTAK1 selective inhibition: state of the art and future opportunities.Modern advances in heterocyclic chemistry in drug discovery.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
TAK1 inhibition in the DFG-out conformation.
@en
TAK1 inhibition in the DFG-out conformation.
@nl
type
label
TAK1 inhibition in the DFG-out conformation.
@en
TAK1 inhibition in the DFG-out conformation.
@nl
prefLabel
TAK1 inhibition in the DFG-out conformation.
@en
TAK1 inhibition in the DFG-out conformation.
@nl
P2093
P2860
P50
P356
P1476
TAK1 inhibition in the DFG-out conformation.
@en
P2093
Christopher Hewson
Christopher Phillips
David G Brown
Iain Kilty
Martin P Green
Peter G Dodd
Philip Cohen
Robert T Smith
Samantha J Hughes
Thomas Ryckmans
P2860
P304
P356
10.1111/CBDD.12169
P577
2013-11-01T00:00:00Z